Cover Image
Market Research Report
Product code 
1084698

Cell Culture Media for Vaccine Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published: | Coherent Market Insights | 197 Pages | Delivery time: 2-3 business days

Price

Back to Top
Cell Culture Media for Vaccine Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Published: May 24, 2022
Coherent Market Insights
Content info: 197 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents

Cell culture media consists an appropriate source of energy and compounds, which supports growth of cells and regulate the cell cycle. A typical culture medium is composed of vitamins, inorganic salts, complement of amino acids, glucose, and serum which acts as source of growth factors, hormones, and attachment factors. Furthermore, the medium also helps to maintain pH and osmolality.

Market Dynamics

Increasing prevalence of infectious diseases is a major factor driving the global cell culture media for vaccine market growth. According to the Centers for Disease Control and Prevention (CDC), in August 2021, around 104 laboratory-confirmed influenza-associated pediatric deaths were reported, where 66 cases were associated with influenza A viruses and 38 cases were associated with influenza B viruses in the U.S. Moreover, the government initiatives for increasing awareness among the populace regarding prevention of diseases facilitated by vaccines is expected to boost the market growth. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2015, flu vaccinations prevented around 1.9 million flu illnesses, 966,000 flu-associated medical visits, and around 67,000 flu-associated hospitalizations, representing 6.5% lowering of disease burden in the U.S.

However, high risk of contamination may hinder the market growth. According to the article published in ResearchGate, 2014, fetal bovine serum (FBS) is known to contain factors such as endotoxins, mycoplasma, viral contaminants, and prions that can lead to bovine spongiform encephalopathy (BSE).

Key features of the study:

  • This report provides in-depth analysis of the global cell culture media for vaccine market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights into market drivers, restraints, opportunities, impact analysis, Porter's analysis, PEST analysis, regulatory scenario, key developments, raw material analysis, and supply chain analysis
  • It profiles key players in the global cell culture media for vaccine market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include HiMedia Laboratories, Thermo Fisher Scientific Inc., Merck KGaA, General Electric Company, Sartorius AG, Proliant, Inc., Bovogen Biologicals Pty. Ltd., Rocky Mountain Biologicals, Valley Biomedical, Moregate BioTech, Atlanta Biologicals, Creative-Biolabs, Life Technologies (India) Pvt Ltd., Axil Scientific Pte Ltd., Indian Immunologicals Limited, Serum Institute of India Pvt. Ltd., Sisco Research Laboratories Pvt. Ltd., and Valneva SE
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global cell culture media for vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell culture media for vaccine market

Detailed Segmentation:

  • Global Cell Culture Media for Vaccine Market, By Media Type:
    • Bovine Derived
      • Fetal bovine serum (FBS)
      • Newborn Calf Serum (NBCS)
      • Adult Bovine Serum (ABS)
      • Bovine Serum Albumin (BSA)
      • Bovine Calf Serum (BCS)
    • Porcine Derived
    • Animal free/Serum Free Cell Culture
  • Global Cell Culture Media for Vaccine Market, By Application:
    • Human Vaccines
    • Animal Vaccines
  • Global Cell Culture Media for Vaccine Market, By Geography:
    • North America
      • By Media Type:
      • Bovine Derived
      • Fetal bovine serum (FBS)
      • Newborn Calf Serum (NBCS)
      • Adult Bovine Serum (ABS)
      • Bovine Serum Albumin (BSA)
      • Bovine Calf Serum (BCS)
      • Porcine Derived
      • Animal free/Serum Free Cell Culture
      • By Application:
      • Human Vaccines
      • Animal Vaccines
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Media Type:
      • Bovine Derived
      • Fetal bovine serum (FBS)
      • Newborn Calf Serum (NBCS)
      • Adult Bovine Serum (ABS)
      • Bovine Serum Albumin (BSA)
      • Bovine Calf Serum (BCS)
      • Porcine Derived
      • Animal free/Serum Free Cell Culture
      • By Application:
      • Human Vaccines
      • Animal Vaccines
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Media Type:
      • Bovine Derived
      • Fetal bovine serum (FBS)
      • Newborn Calf Serum (NBCS)
      • Adult Bovine Serum (ABS)
      • Bovine Serum Albumin (BSA)
      • Bovine Calf Serum (BCS)
      • Porcine Derived
      • Animal free/Serum Free Cell Culture
      • By Application:
      • Human Vaccines
      • Animal Vaccines
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Media Type:
      • Bovine Derived
      • Fetal bovine serum (FBS)
      • Newborn Calf Serum (NBCS)
      • Adult Bovine Serum (ABS)
      • Bovine Serum Albumin (BSA)
      • Bovine Calf Serum (BCS)
      • Porcine Derived
      • Animal free/Serum Free Cell Culture
      • By Application:
      • Human Vaccines
      • Animal Vaccines
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Media Type:
      • Bovine Derived
      • Fetal bovine serum (FBS)
      • Newborn Calf Serum (NBCS)
      • Adult Bovine Serum (ABS)
      • Bovine Serum Albumin (BSA)
      • Bovine Calf Serum (BCS)
      • Porcine Derived
      • Animal free/Serum Free Cell Culture
      • By Application:
      • Human Vaccines
      • Animal Vaccines
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Media Type:
      • Bovine Derived
      • Fetal bovine serum (FBS)
      • Newborn Calf Serum (NBCS)
      • Adult Bovine Serum (ABS)
      • Bovine Serum Albumin (BSA)
      • Bovine Calf Serum (BCS)
      • Porcine Derived
      • Animal free/Serum Free Cell Culture
      • By Application:
      • Human Vaccines
      • Animal Vaccines
      • By Country:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • HiMedia Laboratories *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Thermo Fisher Scientific, Inc.
    • Merck KGaA
    • General Electric Company
    • Sartorius AG
    • Proliant, Inc.
    • Bovogen Biologicals Pty. Ltd.
    • Rocky Mountain Biologicals
    • Valley Biomedical
    • Moregate BioTech
    • Atlanta Biologicals
    • Creative-Biolabs
    • Life Technologies (India) Pvt Ltd.
    • Axil Scientific Pte Ltd.
    • Indian Immunologicals Limited
    • Serum Institute of India Pvt. Ltd.
    • Sisco Research Laboratories Pvt. Ltd.
    • Valneva SE

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI2608

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Media Type
    • Market Snippet, By Application
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Porter's analysis
  • PEST analysis
  • Regulatory Scenario
  • Key Developments
  • Raw material analysis
  • Supply chain analysis

4. Global Cell Culture Media for Vaccine Market, By Media Type, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Bovine Derived
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Fetal bovine serum (FBS)
    • Newborn Calf Serum (NBCS)
    • Adult Bovine Serum (ABS)
    • Bovine Serum Albumin (BSA)
    • Bovine Calf Serum (BCS)
  • Porcine Derived
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Animal free/Serum Free Cell Culture
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

5. Global Cell Culture Media for Vaccine Market, By Application, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Human Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Animal Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Cell Culture Media for Vaccine Market, By Region, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
  • North America
    • Market Size and Forecast, By Media Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Media Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Media Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Media Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Media Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Media Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

7. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • HiMedia Laboratories
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Thermo Fisher Scientific Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Merck KGaA
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • General Electric Company
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sartorius AG
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Proliant, Inc.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bovogen Biologicals Pty. Ltd.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Rocky Mountain Biologicals
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Valley Biomedical
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Moregate BioTech
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Atlanta Biologicals
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Creative-Biolabs
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Life Technologies (India) Pvt Ltd.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Axil Scientific Pte Ltd.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Indian Immunologicals Limited
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Serum Institute of India Pvt. Ltd.
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Valneva SE
    • Company Overview
    • Product Type Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Analyst Views

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact